FMI Reveals: North America’s DNA Synthesis Industry Leading with 41% Share From 2023 To 2033

Exploring the DNA Synthesis Market in North America In the context of regional presence, this market spans North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. North America commands the largest stake in the DNA synthesis market, boasting a substantial 41.0% share during the forecast period. This dominance is attributed to the growing utilization of gene therapy-based medications.

European Advancements in DNA Synthesis” As reported by FMI, Europe is poised to be a fertile ground for DNA synthesis, projecting a substantial 31.4% share during the forecast period. Europe anticipates remarkable market expansion due to the increased focus on research and development in gene synthesis, particularly for vaccine development.

Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-5900

Positioned to attain a value of US$2,898.3 million in 2023, the DNA Synthesis Market is primed for a remarkable ascent, projecting a substantial leap to US$9,999.6 million by 2033. Envisioned to demonstrate an impressive compound annual growth rate (CAGR) of 13.2%, DNA synthesis sales are poised to trace an exceptional trajectory throughout the forecast period.

DNA synthesis, also known as the natural creation of nucleic acid strands through DNA replication, is achieved synthetically using genetic engineering and enzyme chemistry within a laboratory environment. The synthesized versions find diverse applications in fields such as therapeutics, diagnostics, academic research, and industrial research. The growing popularity of DNA synthesis has led to a significant expansion of these applications in recent years.

The growing adoption of gene therapy has contributed to the rise in the need for rapid gene synthesis products. These products provide accurate gene sequences in a short period of time. It enhances the body’s ability to fight against infection and diseases. The utilization of DNA synthesis is increasingly becoming important so as to avoid any alteration to DNA which may result in oncological diseases. In addition to this, the demand for DNA synthesis is also escalating due to its ability to repair the disease of premature ageing.

The synthetic biology segment is a primary growth driver of the DNA synthesis market and accounts for a major share. Again, growing research and development associated with gene synthesis along with constant advancements made in the technological processes such as molecular separation and protein purification technology which assist in developing reliable, fast, and cost-effective solutions also contribute to the target market growth over the projected period.

“Rising application of DNA synthesis in areas like therapeutic, diagnostics, and academic and industrial research will drive the market growth of the same over the forecast period,” says an FMI analyst.  

Key Takeaways:

• Advancements in technological processes will strengthen the future possibilities of the DNA synthesis market.
• Extended wait for approvals of gene synthesizers and products may stunt the market growth.
• North America accounts for 30.2% of the global market share.
• The DNA synthesis market in Europe will likely hold 27.9% of the overall market share.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5900

Competitive Landscape 

Brooks Automation, Inc. (GENEWIZ), Boster Biological Technology, ProteoGenix, Biomatik, ProMab Biotechnologies, Inc, Thermo Fisher Scientific, Inc, Integrated DNA Technologies, Inc, and OriGene Technologies, Inc., among others are some of the major players in the DNA synthesis market profiled in the full version of the report.

Leading market players are focusing on utilizing innovative marketing plans to achieve the highest profits. These enterprises are also keen on mergers, partnerships, and collaboration to strengthen their market presence.

Key Segments

By Service Type:

• Oligonucleotide DNA Synthesis
• Universal Oligonucleotide DNA Synthesis
• Custom Oligonucleotide DNA Synthesis
• Gene DNA Synthesis
• Custom Gene DNA Synthesis
• Gene Library DNA Synthesis

By Application:

• DNA Synthesis for Research and Development
• DNA Synthesis for Academic Applications
• DNA Synthesis for Industrial Applications
• DNA Synthesis for Diagnosis
• DNA Synthesis for Therapeutics

By End User:

• DNA Synthesis for Biopharmaceutical Companies
• DNA Synthesis for Academic and Research Institutes
• DNA Synthesis for Contract Research Organizations

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/5900

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube